Showing results (211-220 of 300) with videos related to
Sort By:
Pageof 30
Nature Communications|April 26, 2020
The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesionsAnita Mitra, David A MacIntyre, George Ntritsos, et al.AIDS (London, England)|July 1, 2010
Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan AfricaCraig R Cohen, Anna-Barbara Moscicki, Mark E Scott, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 1, 1993
Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNAA B Moscicki, J Broering, K Powell, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1999
Risk factors for abnormal anal cytology in young heterosexual womenA B Moscicki, N K Hills, S Shiboski, et al.Vaccine|February 28, 2017
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccineMyron J Levin, Sharon Huang, Anna-Barbara Moscicki, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus typesAnna-Barbara Moscicki, Yifei Ma, Janet Jonte, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 27, 2009
Factors that influence the rate of epithelial maturation in the cervix in healthy young womenLoris Y Hwang, Yifei Ma, Susanna Miller Benningfield, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2011
Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safetyAnna-Barbara Moscicki, Rupert Kaul, Yifei Ma, et al.Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
HPV vaccination of immunocompromised hostsS M Garland, J M L Brotherton, A B Moscicki, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2022
Sexually Transmitted Infections in Pregnant People With Human Immunodeficiency Virus: Temporal Trends, Demographic Correlates, and Association With Preterm BirthMarisa R Young, Carly Broadwell, Deborah Kacanek, et al.Pageof 30